Redalpine Capital I is a closed private equity fund managed by Redalpine.
Switzerland-based Redalpine Capital exited InSphero, a developer of organotypic 3D cell cultures for in-vitro testing, scoring a 10x return.
Read more news concerning Redalpine Capital I
Redalpine is a private equity general partner firm headquartered in Zürich, Switzerland.
View full profile
Registration is fast, free and easy
Already a member?